{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:26:44Z","timestamp":1723595204893},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"DOI":"10.7759\/cureus.66772","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:05:24Z","timestamp":1723561524000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of Mycobacterium indicus pranii in Sepsis Management: A Comprehensive Review of Clinical Outcomes and Therapeutic Potential"],"prefix":"10.7759","author":[{"given":"Devshree","family":"Dhande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Dhok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Anjankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Nagpure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshani","family":"Ganjare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Sepsis. (2023). Accessed. July 27, 2024: https:\/\/www.who.int\/health-topics\/sepsis."},{"key":"ref2","article-title":"Systemic Inflammatory Response Syndrome","author":"Chakraborty RK","year":"2024","unstructured":"Chakraborty RK, Burns B. Systemic Inflammatory Response Syndrome. Statpearls Publishing, Treasure Island, FL; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa070","article-title":"The effects of sepsis on endothelium and clinical implications","volume":"117","author":"Dolmatova EV","year":"2021","unstructured":"Dolmatova EV, Wang K, Mandavilli R, Griendling KK. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2021, 117:60-73. 10.1093\/cvr\/cvaa070","journal-title":"Cardiovasc Res"},{"key":"ref4","unstructured":"Septic shock treatment &amp; management. approach considerations, goals of hemodynamic support, fluid resuscitation. (2024). Accessed: February 3, 2024: https:\/\/emedicine.medscape.com\/article\/168402-treatment."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence-implications for human health and treatment perspectives","volume":"21","author":"Huemer M","year":"2020","unstructured":"Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence-implications for human health and treatment perspectives. EMBO Rep. 2020, 21:e51034. 10.15252\/embr.202051034","journal-title":"EMBO Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12306","article-title":"Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner","volume":"143","author":"Kumar P","year":"2014","unstructured":"Kumar P, Tyagi R, Das G, Bhaskar S. Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner. Immunology. 2014, 143:258-68. 10.1111\/imm.12306","journal-title":"Immunology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.90999","article-title":"Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis","volume":"134","author":"Faujdar J","year":"2011","unstructured":"Faujdar J, Gupta P, Natrajan M, Das R, Chauhan DS, Katoch VM, Gupta UD. Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis. Indian J Med Res. 2011, 134:696-703. 10.4103\/0971-5916.90999","journal-title":"Indian J Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ija.ija_726_23","article-title":"Role of Mycobacterium indicus pranii in clinical outcomes in patients with sepsis: a systematic review and meta-analysis of randomised controlled trials","volume":"67","author":"Saran K","year":"2023","unstructured":"Saran K, Iyengar SS, Sinha N, Abhishek K, Kumar A, Prakash J. Role of Mycobacterium indicus pranii in clinical outcomes in patients with sepsis: a systematic review and meta-analysis of randomised controlled trials. Indian J Anaesth. 2023, 67:1029-35. 10.4103\/ija.ija_726_23","journal-title":"Indian J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque G","year":"2014","unstructured":"Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014, 5:491. 10.3389\/fimmu.2014.00491","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_360_23","article-title":"Mycobacterium indicus pranii (MIP) vaccine: pharmacology, indication, dosing schedules, administration, and side effects in clinical practice","volume":"14","author":"Dogra S","year":"2023","unstructured":"Dogra S, Jain S, Sharma A, Chhabra S, Narang T. Mycobacterium indicus pranii (MIP) vaccine: pharmacology, indication, dosing schedules, administration, and side effects in clinical practice. Indian Dermatol Online J. 2023, 14:753-61. 10.4103\/idoj.idoj_360_23","journal-title":"Indian Dermatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang JM","year":"2007","unstructured":"Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007, 45:27-37. 10.1097\/AIA.0b013e318034194e","journal-title":"Int Anesthesiol Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.23.529651","article-title":"A novel adjuvant formulation induces robust Th1\/Th17 memory and mucosal recall responses in non-human primates","volume":"5","author":"Woodworth JS","year":"2023","unstructured":"Woodworth JS, Contreras V, Christensen D, et al.. A novel adjuvant formulation induces robust Th1\/Th17 memory and mucosal recall responses in non-human primates. bioRxiv. 2023, 5:26-8. 10.1101\/2023.02.23.529651","journal-title":"bioRxiv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou K","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, et al.. Microbiota in health and diseases. Signal Transduct Target Ther. 2022, 7:135. 10.1038\/s41392-022-00974-4","journal-title":"Signal Transduct Target Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27547","article-title":"Repurposing of Mycobacterium indicus pranii for the severe form of COVID-19 patients in India: a cohort study","volume":"94","author":"Shah NN","year":"2022","unstructured":"Shah NN, Dar KA, Quibtiya S, et al.. Repurposing of Mycobacterium indicus pranii for the severe form of COVID-19 patients in India: a cohort study. J Med Virol. 2022, 94:1906-19. 10.1002\/jmv.27547","journal-title":"J Med Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081799","article-title":"Mip-1\u03b1 expression induced by co-stimulation of human monocytic cells with palmitate and TNF-\u03b1 involves the TLR4-IRF3 pathway and is amplified by oxidative stress","volume":"9","author":"Sindhu S","year":"2020","unstructured":"Sindhu S, Akhter N, Wilson A, et al.. Mip-1\u03b1 expression induced by co-stimulation of human monocytic cells with palmitate and TNF-\u03b1 involves the TLR4-IRF3 pathway and is amplified by oxidative stress. Cells. 2020, 9:42-4. 10.3390\/cells9081799","journal-title":"Cells"},{"key":"ref16","article-title":"Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)","author":"Ghlichloo I","year":"2024","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.08.014","article-title":"Controlled release strategies for modulating immune responses to promote tissue regeneration","volume":"219","author":"Dumont CM","year":"2015","unstructured":"Dumont CM, Park J, Shea LD. Controlled release strategies for modulating immune responses to promote tissue regeneration. J Control Release. 2015, 219:155-66. 10.1016\/j.jconrel.2015.08.014","journal-title":"J Control Release"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4263079","article-title":"Animal models of tuberculosis vaccine research: an important component in the fight against tuberculosis","volume":"2020","author":"Gong W","year":"2020","unstructured":"Gong W, Liang Y, Wu X. Animal models of tuberculosis vaccine research: an important component in the fight against tuberculosis. Biomed Res Int. 2020, 2020:4263079. 10.1155\/2020\/4263079","journal-title":"Biomed Res Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387815-1.00025-3","article-title":"Preclinical toxicology of vaccines","author":"Green MD","year":"2012","unstructured":"Green MD, Hussain Al-Humadi N. Preclinical toxicology of vaccines. A Comprehensive Guide to Toxicology in Preclinical Drug Development. Elsevier, Amsterdam, Netherlands; 2012. 6:619-45. 10.1016\/B978-0-12-387815-1.00025-3"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.03.027","article-title":"Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant","volume":"41","author":"Phoolcharoen W","year":"2023","unstructured":"Phoolcharoen W, Shanmugaraj B, Khorattanakulchai N, et al.. Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant. Vaccine. 2023, 41:2781-92. 10.1016\/j.vaccine.2023.03.027","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-016-0151-6","article-title":"Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure","volume":"4","author":"Mebazaa A","year":"2016","unstructured":"Mebazaa A, Laterre PF, Russell JA, et al.. Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure. J Intensive Care. 2016, 4:24. 10.1186\/s40560-016-0151-6","journal-title":"J Intensive Care"},{"key":"ref22","unstructured":"Baptist Health South Florida| Continuing Medical Education. (2023). Accessed. July 27, 2024: https:\/\/cmeonline.baptisthealth.net\/evidence-based-clinical-care-sepsis."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015263","article-title":"Serious adverse events associated with systemic treatments for psoriasis: a network meta\u2010analysis of observational studies and randomized controlled trials","volume":"2024","author":"Guelimi R","year":"2024","unstructured":"Guelimi R, Chaimani A, Parisi R, et al.. Serious adverse events associated with systemic treatments for psoriasis: a network meta\u2010analysis of observational studies and randomized controlled trials. Cochrane Database Syst Rev. 2024, 2024:CD015263. 10.1002\/14651858.CD015263","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.01021","article-title":"Medical Informatics Platform (MIP): a pilot study across clinical Italian cohorts","volume":"11","author":"Redolfi A","year":"2020","unstructured":"Redolfi A, De Francesco S, Palesi F, et al.. Medical Informatics Platform (MIP): a pilot study across clinical Italian cohorts. Front Neurol. 2020, 11:1021. 10.3389\/fneur.2020.01021","journal-title":"Front Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2809973\/v1","article-title":"Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) - outcomes from the first clinical trial of senolytic therapy for Alzheimer\u2019s disease","volume":"2","author":"Gonzales MM","year":"2023","unstructured":"Gonzales MM, Garbarino VR, Kautz T, et al.. Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) - outcomes from the first clinical trial of senolytic therapy for Alzheimer\u2019s disease. Res Sq. 2023, 2:14-6. 10.21203\/rs.3.rs-2809973\/v1","journal-title":"Res Sq"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.01.47","article-title":"An approach to antibiotic treatment in patients with sepsis","volume":"12","author":"Mart\u00ednez ML","year":"2020","unstructured":"Mart\u00ednez ML, Plata-Menchaca EP, Ruiz-Rodr\u00edguez JC, Ferrer R. An approach to antibiotic treatment in patients with sepsis. J Thorac Dis. 2020, 12:1007-21. 10.21037\/jtd.2020.01.47","journal-title":"J Thorac Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03736-w","article-title":"Initial antimicrobial management of sepsis","volume":"25","author":"Niederman MS","year":"2021","unstructured":"Niederman MS, Baron RM, Bouadma L, et al.. Initial antimicrobial management of sepsis. Crit Care. 2021, 25:307. 10.1186\/s13054-021-03736-w","journal-title":"Crit Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020157","article-title":"Individualized hemodynamic management in sepsis","volume":"11","author":"Vir\u00e1g M","year":"2021","unstructured":"Vir\u00e1g M, Leiner T, Rottler M, Ocskay K, Molnar Z. Individualized hemodynamic management in sepsis. J Pers Med. 2021, 11:7-9. 10.3390\/jpm11020157","journal-title":"J Pers Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57309","article-title":"Recent advances in immunomodulatory therapy in sepsis: a comprehensive review","volume":"16","author":"Jain A","year":"2024","unstructured":"Jain A, Singam A, Mudiganti VN. Recent advances in immunomodulatory therapy in sepsis: a comprehensive review. Cureus. 2024, 16:e57309. 10.7759\/cureus.57309","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201712-961OC","article-title":"Inspiratory muscle rehabilitation in critically ill adults. A systematic review and meta-analysis","volume":"15","author":"Vorona S","year":"2018","unstructured":"Vorona S, Sabatini U, Al-Maqbali S, et al.. Inspiratory muscle rehabilitation in critically ill adults. A systematic review and meta-analysis. Ann Am Thorac Soc. 2018, 15:735-44. 10.1513\/AnnalsATS.201712-961OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.07.019","article-title":"Immunotherapy: a promising approach to reverse sepsis-induced immunosuppression","volume":"111","author":"Patil NK","year":"2016","unstructured":"Patil NK, Bohannon JK, Sherwood ER. Immunotherapy: a promising approach to reverse sepsis-induced immunosuppression. Pharmacol Res. 2016, 111:688-702. 10.1016\/j.phrs.2016.07.019","journal-title":"Pharmacol Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00037.2012","article-title":"Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding","volume":"93","author":"Iskander KN","year":"2013","unstructured":"Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, Remick DG. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013, 93:1247-88. 10.1152\/physrev.00037.2012","journal-title":"Physiol Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_1172_2023","article-title":"MIP vaccine in leprosy: a scoping review and future horizons","volume":"6","author":"Narang T","year":"2024","unstructured":"Narang T, Jain S, Kaushal I, Dogra S. MIP vaccine in leprosy: a scoping review and future horizons. Indian J Dermatol Venereol Leprol. 2024, 6:1-9. 10.25259\/IJDVL_1172_2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref34","article-title":"Early Recognition and Initial Management of Sepsis in Adult Patients","author":"King J","year":"2023","unstructured":"King J, Chenoweth CE, England PC, et al.. Early Recognition and Initial Management of Sepsis in Adult Patients. Michigan Medicine University of Michigan, Ann Arbor, MI; 2023."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e418","article-title":"Modified Cardiovascular Sequential Organ Failure Assessment Score in Sepsis: external validation in intensive care unit patients","volume":"38","author":"Ko BS","year":"2023","unstructured":"Ko BS, Ryoo SM, Han E, et al.. Modified Cardiovascular Sequential Organ Failure Assessment Score in Sepsis: external validation in intensive care unit patients. J Korean Med Sci. 2023, 38:e418. 10.3346\/jkms.2023.38.e418","journal-title":"J Korean Med Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang T","year":"2023","unstructured":"Wang T, Tan JB, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open. 2023, 13:e062158. 10.1136\/bmjopen-2022-062158","journal-title":"BMJ Open"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2017.11929552","article-title":"Improving health outcomes through patient education and partnerships with patients","volume":"30","author":"Paterick TE","year":"2017","unstructured":"Paterick TE, Patel N, Tajik AJ, Chandrasekaran K. Improving health outcomes through patient education and partnerships with patients. Proc (Bayl Univ Med Cent). 2017, 30:112-3. 10.1080\/08998280.2017.11929552","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03514-1","article-title":"Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in category II pulmonary tuberculosis in a randomized trial","volume":"7","author":"Sharma SK","year":"2017","unstructured":"Sharma SK, Katoch K, Sarin R, et al.. Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in category II pulmonary tuberculosis in a randomized trial. Sci Rep. 2017, 7:3354. 10.1038\/s41598-017-03514-1","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282956-the-role-of-mycobacterium-indicus-pranii-in-sepsis-management-a-comprehensive-review-of-clinical-outcomes-and-therapeutic-potential","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:05:33Z","timestamp":1723561533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282956-the-role-of-mycobacterium-indicus-pranii-in-sepsis-management-a-comprehensive-review-of-clinical-outcomes-and-therapeutic-potential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.66772","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,13]]}}}